Institutional Investor · CIK 0001274403
ARCH VENTURE MANAGEMENT, LLC
Portfolio data for the last 6 months — sourced from SEC 13F filings
Stocks Held
12
Total Value
$1.10B
Total Shares
61.04M
Latest Filing
Aug 14, 2026
CIK
0001274403
Current Holdings
| Company↕ | Sector↕ | Industry | Period↕ | Filed↓ | Shares↕ | Value ($)↕ | Ownership↕ | Type | P/C/S | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 6,412,780 | $175.52M | 5.5015% | SH | — | View | |
Beam Therapeutics Inc.(BEAM) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 4,540,132 | $155.77M | 4.4131% | SH | — | View |
| Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 3,728,738 | $155.38M | 7.7963% | SH | — | View | |
| Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 6,294,951 | $136.60M | 11.7595% | SH | — | View | |
Erasca, Inc.(ERAS) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 7,091,557 | $129.92M | 2.0429% | SH | — | View |
| Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 12,694,163 | $129.35M | 7.5268% | SH | — | View | |
Maze Therapeutics, Inc.(MAZE) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 4,120,053 | $122.98M | 7.4443% | SH | — | View |
Lyell Immunopharma, Inc.(LYEL) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 3,247,162 | $45.53M | 13.2514% | SH | — | View |
| Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 1,944,426 | $32.80M | 1.5168% | SH | — | View | |
10x Genomics, Inc.(TXG) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 217,834 | $8.35M | 0.1716% | SH | — | View |
Boundless Bio, Inc.(BOLD) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 2,694,095 | $6.74M | 11.9872% | SH | — | View |
Gossamer Bio, Inc.(GOSS) | Healthcare | Biotechnology | 2026-06-30 | 2026-08-14 | 8,055,916 | $1.33M | 1.6479% | SH | — | View |
Showing 1 to 12 of 12 results
1